logo

AXR

Amrep·NYSE
--
--(--)
--
--(--)
7.74 / 10
Outperform

The security demonstrates good fundamental health (7.7/10). Positive indicators: Profit-MV and Cash-UP, though challenges appear in Net income-Revenue and Accounts receivable turnover ratio. Analytical conclusion: excellent.

Fundamental(7.74)SentimentTechnical

Analysis Checks(4/10)

Revenue-MV
Value-0.56
Score1/3
Weight-3.45%
1M Return-3.28%
Profit-MV
Value-0.84
Score2/3
Weight4.91%
1M Return4.71%
Net income-Revenue
Value0.52
Score1/3
Weight-0.31%
1M Return-0.29%
Accounts receivable turnover ratio
Value22.30
Score0/3
Weight-1.20%
1M Return-1.07%
PB-ROE
Value-0.30
Score1/3
Weight-0.91%
1M Return-0.77%
Cash-UP
Value-0.06
Score3/3
Weight26.19%
1M Return21.44%
Cost of sales ratio (%)
Value64.63
Score2/3
Weight1.37%
1M Return1.18%
Asset-MV
Value-0.51
Score1/3
Weight4.21%
1M Return3.89%
Inventory turnover days
Value788.28
Score1/3
Weight1.70%
1M Return1.54%
Cash-MV
Value-0.47
Score3/3
Weight67.49%
1M Return46.52%
Is AXR undervalued or overvalued?
  • AXR scores 7.74/10 on fundamentals and holds a Discounted valuation at present. Backed by its 4.43% ROE, 22.86% net margin, 10.59 P/E ratio, 0.82 P/B ratio, and -15.45% earnings growth, these metrics solidify its Outperform investment rating.